Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant

Pediatrics

Volumn 114, Issue 3, 2004, Pages 703-707

  Michaels, Lisa A ^a,b   Gurian, Michael ^a   Hegyi, Thomas ^a   Drachtman, Richard A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Anticoagulation; Enoxaparin; Low birth weight infant; Low molecular weight heparin; Neonate; Premature; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPERIENCE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL RECORD; NEWBORN; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; VEIN THROMBOSIS; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; LOW BIRTH WEIGHT; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXAPARIN; HEMORRHAGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 16544367956     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0178     Document Type: Article

References (20)

1. Andrew M, David M, Adams M, et al. Venous thromoboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83:1251-1257
2. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low molecular weight heparin in pediatrics patients with thrombotic disease: a dose finding study. J Pediatr. 1996;128:313-318
3. Massicotte P, Julian JA, Marzinotto V, et al. Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients. Thromb Res. 2003;109:93-99
4. Farnoux C, Camard O, Pinquier D, Hurtaud-Roux MF, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998;133:137-140
5. Williams MD, Chalmers EA, Gibson BES. Guidelines: the investigation and management of neonatal hemostasis and thrombosis. Br J Haematol. 2002;119:295-309
6. Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thromboembolic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost. 1992;68:325-330
7. Hirsh J. Low Molecular Weight Heparins. Monograph. Hamilton, Ontario, Canada: Decker Periodicals Inc; 1994
8. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167
9. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939-943
10. Von Ommen CH, Heijboer H, Buller HR, Hirasing RW, Heijmans SA, Peters M. Venous thromboembolism in childhood: a prospective two year registry in The Netherlands. J Pediatr. 2001;139:676-681
11. Andrew M, Ofosu F, Brooker L, et al. The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig. Thromb Res. 1989;56:529-539
12. Andrew M. Developmental hemostasis: relevance to hemostatic problems during childhood. Semin Thromb Hemost. 1995;2:341-356
13. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990;12:95-104
14. Alcore J, McNamera PJ. Pharmacokinetics in the newborn. Adv Drug Del Rev. 2003;29:667-686
15. Dix D, Andrew M, Marzinotto V, et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439-445
16. Phillip AG, Allan WC, Tito AM, Wheeler LR. Intraventricular hemorrhage in preterm infants: declining incidence in the 1980's. Pediatrics. 1989;84:797-801
17. Lesko SM, Mitchell AA, Epstein MF, Louis C, Giacola GP, Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low birth weight infants. N Engl J Med. 1986;314:1156-1160
18. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol. 1995;15:185-191
19. Chang GY, Lueder FL, DiMichele DM, Radkowski MA, McWilliams LJ, Jansen RD. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr. 1997;131:362-366
20. Streif W, Goebel G, Chan AKC, Massicotte MP. Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed. 2003;88:F365-F370